Generics in India - Market Summary, Competitive Analysis and Forecast to 2025
![](/report_cover/4228/generics-in-india-market-summary-competitive-analysis-n-forecast-to-2025_en.gif)
Generics in India - Market @Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Indian generics market had total revenues of $15.7bn in 2020, representing a compound annual growth rate (CAGR) of 8.2% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 0.5% between 2016 and 2020, to reach a total of 97.0% in 2020.
- India is one of the top emerging pharmaceutical markets in the world and the generics market is also thriving. It is the largest provider of generic medicines, with a 20% share of global supply by volume.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume
- What was the size of the India generics market by value in 2020?
- What will be the size of the India generics market in 2025?
- What factors are affecting the strength of competition in the India generics market?
- How has the market performed over the last five years?
- Who are the top competitiors in India's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 COMPANY PROFILES
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Cipla Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 COMPANY PROFILES
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Cipla Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: India generics market value: $ billion, 2016-20
Table 2: India generics market volume: %, 2016-20
Table 3: India generics market geography segmentation: $ billion, 2020
Table 4: India generics market value forecast: $ billion, 2020-25
Table 5: India generics market volume forecast: %, 2020-25
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Lupin Ltd: key facts
Table 10: Lupin Ltd: Annual Financial Ratios
Table 11: Lupin Ltd: Key Employees
Table 12: Lupin Ltd: Key Employees Continued
Table 13: Aurobindo Pharma Ltd: key facts
Table 14: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 15: Aurobindo Pharma Ltd: Key Employees
Table 16: Cipla Limited: key facts
Table 17: Cipla Limited: Annual Financial Ratios
Table 18: Cipla Limited: Key Employees
Table 19: India size of population (million), 2016-20
Table 20: India gdp (constant 2005 prices, $ billion), 2016-20
Table 21: India gdp (current prices, $ billion), 2016-20
Table 22: India inflation, 2016-20
Table 23: India consumer price index (absolute), 2016-20
Table 24: India exchange rate, 2016-20
Table 1: India generics market value: $ billion, 2016-20
Table 2: India generics market volume: %, 2016-20
Table 3: India generics market geography segmentation: $ billion, 2020
Table 4: India generics market value forecast: $ billion, 2020-25
Table 5: India generics market volume forecast: %, 2020-25
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Lupin Ltd: key facts
Table 10: Lupin Ltd: Annual Financial Ratios
Table 11: Lupin Ltd: Key Employees
Table 12: Lupin Ltd: Key Employees Continued
Table 13: Aurobindo Pharma Ltd: key facts
Table 14: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 15: Aurobindo Pharma Ltd: Key Employees
Table 16: Cipla Limited: key facts
Table 17: Cipla Limited: Annual Financial Ratios
Table 18: Cipla Limited: Key Employees
Table 19: India size of population (million), 2016-20
Table 20: India gdp (constant 2005 prices, $ billion), 2016-20
Table 21: India gdp (current prices, $ billion), 2016-20
Table 22: India inflation, 2016-20
Table 23: India consumer price index (absolute), 2016-20
Table 24: India exchange rate, 2016-20
LIST OF FIGURES
Figure 1: India generics market value: $ billion, 2016-20
Figure 2: India generics market volume: %, 2016-20
Figure 3: India generics market geography segmentation: % share, by value, 2020
Figure 4: India generics market value forecast: $ billion, 2020-25
Figure 5: India generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in India, 2020
Figure 7: Drivers of buyer power in the generics market in India, 2020
Figure 8: Drivers of supplier power in the generics market in India, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2020
Figure 11: Drivers of degree of rivalry in the generics market in India, 2020
Figure 1: India generics market value: $ billion, 2016-20
Figure 2: India generics market volume: %, 2016-20
Figure 3: India generics market geography segmentation: % share, by value, 2020
Figure 4: India generics market value forecast: $ billion, 2020-25
Figure 5: India generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in India, 2020
Figure 7: Drivers of buyer power in the generics market in India, 2020
Figure 8: Drivers of supplier power in the generics market in India, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2020
Figure 11: Drivers of degree of rivalry in the generics market in India, 2020